- Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Conditions: Acute Noncardioembolic Stroke; Progressive Stroke During Hospitalization
Intervention: Drug: Phenylephrine
Sponsors: Samsung Medical Center; Samsung Medical Center
Not yet recruiting - verified May 2012 - Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract InfectionCondition: Acute Cough
Intervention: Drug: FP01
Sponsors: Cerecor Inc; Cerecor Inc
Recruiting - verified May 2012 - Condition: Dry Eye
Interventions: Other: Blink Tears lubricating Eye Drops; Other: Blink Gel Tears Lubricating Eye Drops; Other: Systane Balance Lubricant Eye Drop
Sponsors: Ophthalmic Consultants of Connecticut; Ophthalmic Consultants of Connecticut
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Su-Huang antitussive capsule; Drug: Sugar pill
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified April 2012 - Conditions: Intraocular Pressure (IOP); Tear Break-Up Time
Interventions: Drug: IOPIZE© Latanoprost eyedrops; Drug: GALAXIA© Latanoprost eyedrops; Drug: Latanoprost RATIOPHARM© latanoprost eyedrops
Sponsors: University of Cantanzaro; University of Cantanzaro
Recruiting - verified April 2012 - Condition: Upper Respiratory Infections
Intervention: Drug: IFF flavor 316 282, Paracetamol , Phenylephrine, Guaifenesin
Sponsors: Novartis; Novartis; Novartis Consumer Health
Recruiting - verified April 2012 - Conditions: Uterine Atony; Hypotension
Interventions: Drug: Oxytocin; Drug: Oxytocin
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified March 2012 - Condition: Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
Interventions: Device: HYABAK®; Device: HYLO-COMOD®
Sponsors: Laboratoires Thea; Laboratoires Thea; AIXIAL
Not yet recruiting - verified March 2012 - Condition: Control of Arterial Blood Pressure
Intervention: Other: noradrenaline
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand; Aguettant laboratory
Not yet recruiting - verified February 2012 - Condition: Contact Lens Related Dry Eye Syndrome
Interventions: Device: OPTIVEtm Plus; Procedure: No treatment; Device: Blink Contacts® Eye Drops
Sponsors: Optometric Technology Group Ltd; Optometric Technology Group Ltd; Allergan
Recruiting - verified February 2012 - Condition: Glaucoma
Intervention: Drug: Aqueous Suppressant Eye Drops
Sponsors: Credit Valley EyeCare; Credit Valley EyeCare; Canadian Glaucoma Clinical Research Council
Recruiting - verified February 2012 - Conditions: Flu; Cold; Respiratory Tract Allergies
Interventions: Drug: naphazoline hydrocloride; Drug: Naphazoline hydrocloride + Pheniramine Maleate + Panthenol
Sponsors: EMS; EMS
Not yet recruiting - verified November 2011 - Condition: Diabetic Macular Edema
Interventions: Drug: dexamethasone - Cyclodextrin eye drops; Other: intravitreal Avastin injection +/- macular laser
Sponsors: King Saud University; King Saud University
Not yet recruiting - verified January 2012 - Condition: Neuropathic Pain
Interventions: Drug: Dextromethorphan (drug used like antitussive); Drug: Memantine (drug used in Alzheimer's disease); Drug: Placebo (lactose)
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand; Dr Pascale Picard/Dr Fabienne Riaux-Marcaillou/Dr Noémie Delage, Pain Clinic,Clermont-Ferrand Hospital; Dr Malou Navez, Pain Clinic, Saint-Etienne Hopital; Dr Marc Sorel, Pain Clinic, Nemours Hospital; Dr Anne-Margot Duclot, Pain Clinic, Paris Rotschild Hospital; Dr Monique Belon, Pain Clinic, Aurillac Hospital; Dr Marie-Christine Crosmary/Dr Renato Colamarino, Pain Clinic, Vichy Hospital; Dr Mohamed El Ayadi, Pain Clinic, Issoire Hospital; Dr Géraldine Brumauld de Montgazon, Pain Clinic, La Rochelle Hospital; Pr Claude Dubray, Clinical Pharmacology Center, Inserm 501, Clermont-Ferrand Hospital
Not yet recruiting - verified May 2012 - Condition: Complications; Cesarean Section
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Naestved Hospital; Naestved Hospital; Rigshospitalet, Denmark
Recruiting - verified March 2012 - Condition: Disorder of Urinary Stent
Interventions: Drug: Placebo; Drug: Terazosine; Drug: Tolterodine; Drug: Tolterodine + Terazosin
Sponsors: Urmia University of Medical Sciences; Urmia University of Medical Sciences
Recruiting - verified January 2012 - Condition: Vasomotor Rhinitis
Intervention: Drug: Pseudoephedrine / Levocetirizine
Sponsors: Hanmi Pharmaceutical Company Limited; Hanmi Pharmaceutical Company Limited
Recruiting - verified January 2012 - Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SABCondition: Hysterectomy
Interventions: Drug: General Anesthesia + Spinal anesthesia combined; Drug: General Anesthesia (control group)
Sponsors: University of Saskatchewan; University of Saskatchewan
Not yet recruiting - verified January 2012 - Condition: Anterior Uveitis
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution; Drug: Prednisolone Acetate (1%) Eyedrops; Drug: 100 mM sodium citrate buffer solution; Drug: Placebo Eyedrops
Sponsors: Eyegate Pharmaceuticals, Inc.; Eyegate Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Irvine Gass Syndrome
Intervention: Behavioral: if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified December 2011 - Conditions: Overactive Bladder; Overactive Urinary Bladder
Interventions: Drug: MK-4618; Drug: Tolterodine ER; Drug: MK-1468 and Tolterodine ER; Other: Placebo (MK-4618); Other: Placebo (Tolterodine ER); Drug: Prophylactic Antibiotic
Sponsors: Merck; Merck
Recruiting - verified February 2012 - Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
Sponsors: Kedrion S.p.A.; Kedrion S.p.A.
Not yet recruiting - verified April 2012 - Conditions: Intra-operative Hypotension; Carotid Stenosis
Interventions: Drug: Administration of phenylephrine; Drug: Administration of ephedrine
Sponsors: UMC Utrecht; G.J. de Borst
Not yet recruiting - verified October 2011 - Conditions: Upper Respiratory Tract Infection; Nasal Congestion; Rhinorrhea; Sneezing
Interventions: Drug: Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets; Drug: Paracetamol (500 mg) tablets
Sponsors: Novartis; Novartis; NOVARTIS BIOCIÊNCIAS S.A.
Not yet recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: Preservative free tafluprost 0.0015% eye drops; Drug: Preservative free timolol 0.5% eye drops; Drug: Preservative free FDC of tafluprost 0.0015% and timolol 0.5% eye drops
Sponsors: Santen Oy; Santen Oy
Not yet recruiting - verified September 2011 - Conditions: Glaucoma, Open-Angle; Ocular Hypertension
Interventions: Drug: refrigeration free latanoprost; Drug: latanoprost eye drops
Sponsors: Aurolab; Aurolab
Recruiting - verified September 2011 - Conditions: Glaucoma; Glaucoma Suspect
Intervention: Other: Encouragement to attempt eye drop instillation with a specific technique
Sponsors: Oftalmologia Hospital Sotero del Rio; Oftalmologia Hospital Sotero del Rio
Recruiting - verified August 2011 - Conditions: Preeclampsia; Pregnancy Toxemias
Interventions: Drug: Metaraminol; Drug: Ephedrine
Sponsors: Instituto Materno Infantil Prof. Fernando Figueira; Instituto Materno Infantil Prof. Fernando Figueira
Recruiting - verified October 2011 - Condition: Glaucoma, Open-Angle
Interventions: Other: Video education on proper eye drop instillation technique; Other: Placebo video education on healthy eating tips
Sponsors: Northwestern University; Northwestern University
Recruiting - verified August 2011 - Conditions: Meibomian Gland Dysfunction; Posterior Blepharitis
Interventions: Drug: Loteprednol/tobramycin; Drug: Loteprednol; Drug: Bausch + Lomb Advanced Eye Relief Lubricant Eye Drops
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary; Bausch & Lomb, Inc.
Recruiting - verified October 2011 - Condition: Hypotension
Interventions: Drug: Phenylephrine bolus; Drug: phenylephrine infusion
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified January 2012 - Conditions: Dry Eye; Sjogren's Syndrome; Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
Sponsors: Michigan Cornea Consultants, PC; Michigan Cornea Consultants, PC; Kresge Eye Institute
Recruiting - verified July 2011 - Condition: Orthopedic Surgery of Lower Limb
Interventions: Drug: phenylephrine infusion; Drug: patients receiving saline infusion
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse
Recruiting - verified February 2012 - Condition: Dry Eye
Interventions: Drug: B & L Soothe Lubricant Eye Drops; Drug: Liposic EDO; Drug: OcuFresh Eye Wash
Sponsors: University of Rochester; University of Rochester; Bausch & Lomb, Inc.
Recruiting - verified May 2012 - Condition: Anesthetic Complication Spinal
Intervention: Drug: Phenylephrine
Sponsors: American University of Beirut Medical Center; American University of Beirut Medical Center
Not yet recruiting - verified July 2011 - Conditions: Macular Degeneration; Age-related Macular Degeneration
Intervention: Drug: pazopanib eye drops
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Flexible Nasendoscopy
Interventions: Drug: 0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride; Drug: 0.05% xylometazoline hydrochloride; Drug: Isotonic normal saline
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified June 2011 - Condition: Chronic Rhinitis
Interventions: Drug: Placebo; Drug: Guaifenesin
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; Pfizer
Recruiting - verified May 2011 - Condition: Urinary Bladder, Overactive
Interventions: Drug: MK-4618 low-dose; Drug: MK-4618 mid-low dose; Drug: MK-4618 mid-high dose; Drug: tolterodine ER; Drug: Placebo for MK-4618; Drug: Placebo for tolterodine ER; Drug: MK-4618 high dose
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Open-angle Glaucoma; Ocular Hypertension
Interventions: Drug: Brinzolamide 1% / brimonidine 0.2% ophthalmic suspension; Drug: Brinzolamide 1% Eye drops, suspension BID (AZOPT); Drug: Brimonidine Tartrate
Sponsors: Alcon Research; Alcon Research
Recruiting - verified November 2011 - Condition: Overactive Bladder
Interventions: Drug: Tolterodine ER; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Dry Eye Syndromes
Interventions: Drug: Formulation 1: Eye Drops New Platform (EDNP) - 1; Drug: Formulation 2: EDNP - 2; Drug: carboxymethylcellulose sodium based artificial tear
Sponsors: Allergan; Allergan
Recruiting - verified May 2012 - Condition: Caesarean Section
Interventions: Drug: Phenylephrine; Device: Lower limb compression; Other: Placebo
Sponsors: Anestesiavdelingen Baerum Sykehus; Anestesiavdelingen Baerum Sykehus
Recruiting - verified November 2011 - Conditions: Nasal Congestion and Inflammations; Rhinitis
Interventions: Drug: brompheniramine + phenylephrine; Drug: Brompheniramine + pseudoephedrine
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified July 2011 - Conditions: Nasal Congestion and Inflammations; Rhinitis
Interventions: Drug: Group 1; Drug: Group 2
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified July 2011 - Condition: Normal Subjects, Subjects Who Experience Dry Eye Symptoms, Subjects at Risk for Developing Dry Eye and Experienced Contact Lens Wearers.
Interventions: Other: Patient-directed or physician-recommended interventions.; Other: Environmental Chamber; Drug: Eye Drop Intervention; Other: Contact Lens Intervention
Sponsors: University of Rochester; University of Rochester
Recruiting - verified May 2012 - Condition: Primary Vascular Dysregulation
Interventions: Drug: Brimonidine; Drug: Latanoprost; Drug: Placebo
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified September 2011 - Conditions: Inflammation; Cough; Rhinitis
Interventions: Drug: diphenhydramine + dropropizine + pseudoephedrine; Drug: Dropropizine and fixed dose combination of pseudoephedrine hydrochloride + brompheniramine maleate (Dimetapp® elixir).
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified July 2011 - Condition: Cataract Surgery
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified February 2012 - Conditions: Ocular Hypertension; Open-Angle Glaucoma
Intervention: Drug: Tafluprost 0.0015%
Sponsors: FinnMedi Oy; FinnMedi Oy; University of Tampere; The Laboratory and Pharmacy Public Utility of the Pirkanmaa Hospital District
Recruiting - verified June 2011 - Conditions: Pterygium; Inflammation
Interventions: Drug: Intralesional injection of bevacizumab; Drug: Topical antihistamine and vasoconstrictor
Sponsors: Khon Kaen University; Khon Kaen University
Recruiting - verified July 2010 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Trinitrin; Drug: Neosynephrine 10% collyrium; Drug: Iontophoresis with acetylcholine delivery; Device: Dynamic Vessel Analyzer
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2011 - Condition: Moderate to Severe Chronic Blepharitis (Posterior and/or Anterior)
Interventions: Drug: Azithromycin; Drug: Povidone
Sponsors: Laboratoires Thea; Laboratoires Thea; KEYRUS; VEEDA
Recruiting - verified June 2011 - Condition: Pancreatic Cancer
Interventions: Other: restrictive perioperative fluid management; Other: Liberal perioperative fluid management
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified May 2012 - Conditions: Overactive Bladder; Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified December 2011 - Condition: Lower Urinary Tract Symptoms
Interventions: Drug: dutasteride 0.5 mg, used with tolterodine ER 4mg or placebo; Drug: dutasteride
Sponsors: Siami, Paul F., M.D.; Siami, Paul F., M.D.; GlaxoSmithKline; Pfizer
Recruiting - verified July 2011 - Condition: Vascular Sensitivity
Intervention: Drug: phenylephrine and nitroglycerin
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Conditions: Cataract; Phacoemulsification; Mydriasis; Pseudoexfoliation Syndrome
Intervention: Procedure: Intracameral injection of mydriatic agent
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified May 2008 - Conditions: Preeclampsia; Hypotension
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: OBESITY; HYPERTENSION; PURE AUTONOMIC FAILURE; SHY-DRAGER SYNDROME
Interventions: Drug: Trimethaphan; Drug: Trimethaphan; Drug: Pseudoephedrine
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012
 |
Join Clinical trials for Ephedrine |
